Showing results (41-50 of 282) with videos related to
Sort By:
Pageof 29
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 7, 2023
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)Rosario García-Campelo, Ivana Sullivan, Edurne Arriola, et al.BMC Cancer|October 25, 2014
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practiceDaniel Castellano, Javier Puente, Guillermo de Velasco, et al.Journal of Thoracic Disease|June 17, 2024
Indeterminate pulmonary nodules and prior malignancy: survival and recurrence after surgery in newly diagnosed stage I non-small cell lung cancerJosé Franco, Genaro Galán, Elvira Bondía, et al.Advances in Therapy|November 10, 2011
An overview of letrozole in postmenopausal women with hormone-responsive breast cancerAgustí Barnadas, Laura G Estévez, Ana Lluch-Hernández, et al.Journal of Medical Economics|March 8, 2023
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Javier De Castro, et al.The Oncologist|May 16, 2012
High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patientsChandra Bartholomeusz, Ana M Gonzalez-Angulo, Ping Liu, et al.Cancer Treatment Reviews|October 17, 2008
Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancerMontserrat Muñoz, Laura G Estévez, Isabel Alvarez, et al.The Oncologist|April 3, 2012
Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancerMiguel Martín, Anatoly Makhson, Joseph Gligorov, et al.Expert Review of Pharmacoeconomics & Outcomes Research|September 13, 2014
Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspectiveMiguel Ángel Seguí, Carlos Crespo, Javier Cortés, et al.Cancer Treatment Reviews|October 4, 2005
Fulvestrant ("Faslodex"): clinical experience from the Compassionate Use ProgrammeGuenther G Steger, Maya Gips, Sergio D Simon, et al.Pageof 29